Craft

Dr Hoenle

Stock Price

€9.9

2024-10-29

Market Capitalization

€60.1 M

2024-10-29

Revenue

€93.7 M

FY, 2025

Dr Hoenle Summary

Company Summary

Overview
The Dr. Hönle AG is one of the leading suppliers of industrial UV technologies worldwide. Together with our subsidiaries, we develop, produce and sell LED UV units and LED UV equipment, UV units, UV equipment, inert UV dryers, UV lamps and UV bulbs, IR lamps, UV measuring technology, reflectors, solar simulation systems and Electronic Power Supplies. In addition, UV dryers for rotary printing (sheet-fed offset printing, web offset printing), UV systems for inkjet printing and flexo printing, infrared and hot air drying systems, powder-coating and powder extraction systems, UV medium-pressure bulbs and UV low-pressure lamps, UV lamps for air, water and surface disinfection, quartz glass and quartz glass components and industrial adhesives and potting & sealing compounds are developed, produced and sold within the Hönle Group. Our products are used in a wide range of industrial applications: in printing (web or 3D printing), in coating and finishing (for example 3D coating), in bonding or casting, for surface disinfection or water disinfection, in solar simulation and photovoltaics or for fluorescence testing. Our strength lies in our ability to customise products to suit the specific requirements of our customers. We are particularly proud of our highly integrated production.
Type
Public
Status
Active
HQ
Gräfelfing, DE | view all locations
Website
https://www.hoenle.de/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

9 locations detected

  • Gräfelfing, Bayern HQ

    Germany

    1 Lochhamer Schlag

  • Batavia, IL

    United States

    1888 E Fabyan Pkwy #7

  • Marlborough, MA

    United States

    261 Cedar Hill St Bldg. C, Marlborough

  • Torrington, CT

    United States

    142 Industrial Ln

  • Shanghai Shi

    China

    821, 800 Shangcheng Rd, Pudong Xinqu

  • Lyon, Auvergne-Rhône-Alpes

    France

    38 Rue Delandine

and 3 others

Dr Hoenle Financials

Summary Financials

Revenue (Q1, 2026)
€21.5M
Gross profit (Q1, 2026)
€14.3M
Net income (Q1, 2026)
(€1.5M)
Cash (Q1, 2026)
€6.7M
EBIT (Q1, 2026)
(€764.0K)
Enterprise value
$101.2M

Footer menu